Page last updated: 2024-11-06

diploptene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diploptene is a naturally occurring triterpene isolated from the bark of the Dipteryx odorata tree. It exhibits anti-inflammatory, anti-oxidant, and antimicrobial properties. It has been shown to inhibit the production of pro-inflammatory cytokines like TNF-alpha and IL-6, and to reduce oxidative stress. Diploptene is of interest for its potential medicinal applications, particularly in the treatment of inflammatory and infectious diseases. Studies are ongoing to investigate its therapeutic efficacy and to develop new drug candidates based on its structure.'

diploptene: biosynthesized in a cell-free system from Acetobacter pasteurianum in the presence of squalene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hop-22(29)-ene : A triterpene consisting of hopane having a C=C double bond at the 22(29)-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92155
CHEMBL ID455613
CHEBI ID4648
MeSH IDM0092260

Synonyms (14)

Synonym
hopene
LMPR04000001
CHEBI:4648 ,
a'-neogammacer-22(29)-ene
C06310
diploptene
1615-91-4
hop-22(29)-ene
22(29)-hopene
CHEMBL455613
(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-3-prop-1-en-2-yl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysene
J-009844
DTXSID30936540
Q14124950
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpeneA C30 terpene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
diploterol biosynthesis14
hopanoid biosynthesis (bacteria)830
diploterol and cycloartenol biosynthesis27

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.13)18.7374
1990's4 (10.26)18.2507
2000's14 (35.90)29.6817
2010's13 (33.33)24.3611
2020's6 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.67 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (10.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (89.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]